Vimian schedules Q1 2026 interim report release and investor audiocast

Vimian Group AB ( (SE:VIMIAN) ) just unveiled an update.

Vimian Group AB has announced that it will publish its interim report for the first quarter of 2026 on 29 April at 07:45 CET, followed by an audiocast for investors, analysts and media at 09:00 CET. CEO Alireza Tajbakhsh and CFO Carl-Johan Zetterberg Boudrie will present and comment on the results in English, with participants able to join via telephone or webcast and access related presentation materials on the company’s website, underscoring Vimian’s continued efforts to maintain transparency and engagement with the capital markets.

The scheduled interim report and accompanying webcast offer stakeholders an opportunity to assess Vimian’s performance and strategic progress across its animal health segments early in the financial year. The event format, including a live question-and-answer session, is likely to provide additional insights into operational trends and market conditions affecting the company’s diversified global veterinary portfolio.

The most recent analyst rating on (SE:VIMIAN) stock is a Sell with a SEK25.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.

More about Vimian Group AB

Vimian Group AB is a global animal health company operating across Specialty Pharma, MedTech, Veterinary Services and Diagnostics, with a focus on bringing innovative treatments and tools to veterinary professionals and pet owners. Headquartered in Stockholm, the group serves clinics and laboratories in more than 80 markets, employs about 1,300 people and generates annual revenues of roughly EUR 425 million.

Average Trading Volume: 295,148

Technical Sentiment Signal: Buy

Current Market Cap: SEK15.88B

See more insights into VIMIAN stock on TipRanks’ Stock Analysis page.